Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Walker Ulrich A.

A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc

Saketkoo L.A.; Frech T.; Varju C.; Domsic R.; Farrell J.; Gordon J.K.; Mihai C.; Sandorfi N.; Shapiro L.; Poole J.; Volkmann E.R.; Lammi M.; McAnally K.; Alexanderson H.; Pettersson H.; Hant F.; Kuwana M.; Shah A.A.; Smith V.; Hsu V.; Kowal-Bielecka O.; Assassi S.; Cutolo M.; Kayser C.; Shanmugam V.K.; Vonk M.C.; Fligelstone K.; Baldwin N.; Connolly K.; Ronnow A.; Toth B.; Suave M.; Farrington S.; Bernstein E.J.; Crofford L.J.; Czirjak L.; Jensen K.; Hinchclif M.; Hudson M.; Lammi M.R.; Mansour J.; Morgan N.D.; Mendoza F.; Nikpour M.; Pauling J.; Riemekasten G.; Russell A.-M.; Scholand M.B.; Seigart E.; Rodriguez-Reyna T.S.; Hummers L.; Walker U.; Steen V.. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2021.

A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: The UPSIDE study protocol

Spierings J.; Van Rhenen A.; Welsing P.M.W.; Marijnissen A.C.A.; De Langhe E.; Del Papa N.; Dierickx D.; Gheorghe K.R.; Henes J.; Hesselstrand R.; Kerre T.; Ljungman P.; Van De Loosdrecht A.A.; Marijt E.W.A.F.; Mayer M.; Schmalzing M.; Schroers R.; Smith V.; Voll R.E.; Vonk M.C.; Voskuyl A.E.; De Vries-Bouwstra J.K.; Walker U.A.; Wuttge D.M.; Van Laar J.M.. BMJ Open. 2021.

A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model

Kocher A.; Ndosi M.; Denhaerynck K.; Simon M.; Dwyer A.A.; Distler O.; Hoeper K.; Kunzler-Heule P.; Redmond A.C.; Villiger P.M.; Walker U.A.; Nicca D.. Orphanet Journal of Rare Diseases. 2021.

Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis

Manoil D.; Courvoisier D.S.; Gilbert B.; Moller B.; Walker U.A.; Von Muehlenen I.; Rubbert-Roth A.; Finckh A.; Bostanci N.. Rheumatology (United Kingdom). 2021.

Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction

Shaw Y.; Courvoisier D.S.; Scherer A.; Ciurea A.; Lehmann T.; Jaeger V.K.; Walker U.A.; Finckh A.. RMD Open. 2021.

Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis

Lechtenboehmer C.A.; Burkard T.; Reichenbach S.; Walker U.A.; Burden A.M.; Hugle T.. Arthritis Research and Therapy. 2021.

Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: Results from the β-Confident Registry

Walker U.A.; Tilson H.H.; Hawkins P.N.; Van Der Poll T.; Noviello S.; Levy J.; Vritzali E.; Hoffman H.M.; Kuemmerle-Deschner J.B.. RMD Open. 2021.

Natural variability in the disease course of SSC-ILD: Implications for treatment

Vonk M.C.; Walker U.A.; Volkmann E.R.; Kreuter M.; Johnson S.R.; Allanore Y.. European Respiratory Review. 2021.

Patient and healthcare professional eHealth literacy and needs for systemic sclerosis support: a mixed methods study.

Kocher A; Simon M; Dwyer AA; Blatter C; Bogdanovic J; Künzler-Heule P; Villiger PM; Dan D; Distler O; Walker UA; Nicca D. RMD open. 2021.

Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network

Kalweit M.; Walker U.A.; Finckh A.; Muller R.; Kalweit G.; Scherer A.; Boedecker J.; Hugle T.. PLoS One. 2021.

Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies

Fallet B.; Walker U.A.. Expert Review of Clinical Pharmacology. 2020.

Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals

Burkhard J.; Ciurea A.; Gabay C.; Hasler P.; Muller R.; Niedrig M.; Fehr J.; Villiger P.; Visser L.G.; de Visser A.W.; Walker U.A.; Hatz C.; Buhler S.. VACCINE. 2020.

Lumbar Radiculitis as a Complication of Vaccination against Tick-Borne Encephalitis: A Differential Diagnosis of Low Back Pain and Nerve Root Compression

Kingston C.; Zech G.; Pauli C.; Walker U.. Case Reports in Medicine. 2020.

Mild Course of COVID-19 and Spontaneous Virus Clearance in a Patient With Depleted Peripheral Blood B Cells Due to Rituximab Treatment

Fallet B.; Kyburz D.; Walker U.A.. Arthritis and Rheumatology. 2020.

Prematurely aging mitochondrial DNA mutator mice display subchondral osteopenia and chondrocyte hypertrophy without further osteoarthritis features

Geurts J.; Nasi S.; Distel P.; Muller-Gerbl M.; Prolla T.A.; Kujoth G.C.; Walker U.A.; Hugle T.. Scientific Reports. 2020.

Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

Jaeger V.K.; Tikly M.; Xu D.; Siegert E.; Hachulla E.; Airo P.; Valentini G.; Matucci Cerinic M.; Distler O.; Cozzi F.; Carreira P.; Allanore Y.; Muller-Ladner U.; Ananieva L.P.; Balbir-Gurman A.; Distler J.H.W.; Czirjak L.; Li M.; Henes J.; Jimenez S.A.; Smith V.; Damjanov N.; Denton C.P.; Delgaldo F.; Saketkoo L.A.; Walker U.A.. Rheumatology (United Kingdom). 2020.

Systemic sclerosis in sub-saharan Africa: A systematic review

Erzer J.N.; Jaeger V.K.; Tikly M.; Walker U.A.. Pan African Medical Journal. 2020.

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

Hoffmann-Vold A.-M.; Maher T.M.; Philpot E.E.; Ashrafzadeh A.; Barake R.; Barsotti S.; Bruni C.; Carducci P.; Carreira P.E.; Castellvi I.; Del Galdo F.; Distler J.H.W.; Foeldvari I.; Fraticelli P.; George P.M.; Griffiths B.; Guillen-Del-Castillo A.; Hamid A.M.; Horvath R.; Hughes M.; Kreuter M.; Moazedi-Fuerst F.; Olas J.; Paul S.; Rotondo C.; Rubio-Rivas M.; Seferian A.; Tomcik M.; Uzunhan Y.; Walker U.A.; Wiesik-Szewczyk E.; Distler O.. Lancet Rheumatology. 2020.

Travel patterns, risk behaviour and health problems of travellers with rheumatic diseases compared to controls: A multi-centre, observational study

Schmid N.; Ciurea A.; Gabay C.; Hasler P.; Fehr J.; Muller R.; Villiger P.; Walker U.; Hatz C.; Buhler S.. Travel Medicine and Infectious Disease. 2020.

Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study

Blagojevic J.; Abignano G.; Avouac J.; Cometi L.; Frerix M.; Bellando-Randone S.; Guiducci S.; Bruni C.; Huscher D.; Jaeger V.K.; Lorand V.; Maurer B.; Nihtyanova S.; Riemekasten G.; Siegert E.; Tarner I.H.; Vettori S.; Walker U.A.; Czirjak L.; Denton C.P.; Distler O.; Allanore Y.; Muller-Ladner U.; Moggi-Pignone A.; Matucci-Cerinic M.; Del Galdo F.. CLINICAL RHEUMATOLOGY. 2020.

Brief Report: Influence of Disease Activity in Rheumatoid Arthritis on Radiographic Progression of Concomitant Interphalangeal Joint Osteoarthritis.

Lechtenboehmer CA; Jaeger VK; Kyburz D; Walker UA; Hügle T. Arthritis and Rheumatology. 2019.

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: A DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey

Blagojevic J.; Bellando-Randone S.; Abignano G.; Avouac J.; Cometi L.; Czirjak L.; Denton C.P.; Distler O.; Frerix M.; Guiducci S.; Huscher D.; Jaeger V.K.; Lorand V.; Maurer B.; Nihtyanova S.; Riemekasten G.; Siegert E.; Tarner I.H.; Vettori S.; Walker U.A.; Allanore Y.; Muller-Ladner U.; Del Galdo F.; Matucci-Cerinic M.. Arthritis Research and Therapy. 2019.

Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database.

Carreira PE; Carmona L; Joven BE; Loza E; Andréu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker U; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019.

Do Patients With Skin Psoriasis Show Subclinical Axial Inflammation on Magnetic Resonance Imaging of the Sacroiliac Joints and Entire Spine?

Bratu VA; Häusermann P; Walker UA; Daikeler T; Zubler V; Jaeger VK; Weber U; Studler U. ARTHRITIS CARE & RESEARCH. 2019.

Fast track algorithm: How to differentiate a “scleroderma pattern” from a “non-scleroderma pattern”

Smith V.; Vanhaecke A.; Herrick A.L.; Distler O.; Guerra M.G.; Denton C.P.; Deschepper E.; Foeldvari I.; Gutierrez M.; Hachulla E.; Ingegnoli F.; Kubo S.; Muller-Ladner U.; Riccieri V.; Sulli A.; van Laar J.M.; Vonk M.C.; Walker U.A.; Cutolo M.. AUTOIMMUNITY REVIEWS. 2019.

Mitochondrial DNA mutations and respiratory chain dysfunction in idiopathic and connective tissue disease-related lung fibrosis

Jaeger V.K.; Lebrecht D.; Nicholson A.G.; Wells A.; Bhayani H.; Gazdhar A.; Tamm M.; Venhoff N.; Geiser T.; Walker U.A.. Scientific Reports. 2019.

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

Becker M.; Graf N.; Sauter R.; Allanore Y.; Curram J.; Denton C.P.; Khanna D.; Matucci-Cerinic M.; de Oliveira Pena J.; Pope J.E.; Distler O.; Guiducci S.; Walker U.; Jaeger V.; Bannert B.; Lapadula G.; Becvarare R.; Cutolo M.; Valentini G.; Siegert E.; Rednic S.; Montecucco C.; Carreira P.E.; Novak S.; Czirjak L.; Varju C.; Chizzolini C.; Allai D.; Kucharz E.J.; Cozzi F.; Rozman B.; Mallia C.; Gabrielli A.; Bancel D.F.; Airo P.; Hesselstrand R.; Martinovic D.; Balbir-Gurman A.; Braun-Moscovici Y.; Hunzelmann N.; Pellerito R.; Caramaschi P.; Black C.; Damjanov N.; Henes J.; Santamaria V.O.; Heitmann S.; Seidel M.; Pereira Da Silva J.A.; Stamenkovic B.; Selmi C.F.; Tikly M.; Denisov L.N.; Muller-Ladner U.; Engelhart M.; Hachulla E.; Riccieri V.; Ionescu R.M.; Mihai C.; Sunderkotter C.; Kuhn A.; Schett G.; Distler J.; Meroni P.; Ingegnoli F.; Mouthon L.; De Keyser F.; Smith V.; Cantatore F.P.; Corrado A.; Ullman S.; Iversen L.; Pozzi M.R.; Eyerich K.; Hein R.; Knott E.; Wiland P.; Szmyrka-Kaczmarek M.; Sokolik R.; Morgiel E.; Madej M.; Alegre-Sancho J.J.; Krummel-Lorenz B.; Saar P.; Aringer M.; Gunther C.; Anne E.; Westhovens R.; De Langhe E.; Lenaerts J.; Anic B.; Baresic M.; Mayer M.; Uprus M.; Otsa K.; Yavuz S.; Radominski S.C.; de Souza Muller C.; Azevedo V.F.; Popa S.; Zenone T.; Stebbings S.; Highton J.; Mathieu A.; Vacca A.; Stamp L.; Chapman P.; O'donnell J.; Solanki K.; Doube A.; Veale D.; O'rourke M.; Loyo E.; Li M.; Rosato E.; Amoroso A.; Gigante A.; Oksel F.; Yargucu F.; Tanaseanu C.-M.; Popescu M.; Dumitrascu A.; Tiglea I.; Foti R.; Visalli E.; Benenati A.; Amato G.; Ancuta C.; Chirieac R.; Villiger P.; Adler S.; Dan D.; de la Pena Lefebvre P.G.; Rubio S.R.; Exposito M.V.; Sibilia J.; Chatelus E.; Gottenberg J.E.; Chifflot H.; Litinsky I.; Del Galdo F.; Venalis A.; Saketkoo L.A.; Lasky J.A.; Kerzberg E.; Montoya F.; Cosentino V.; Limonta M.; Brucato A.L.; Lupi E.; Spertini F.; Ribi C.; Buss G.; Martin T.; Guffroy A.; Poindron V.; Chung L.; Schmeiser T.; Zebryk P.; Riso N.; Riemekasten G.; Rezus E.; Sarzi Puttini P.. Annals of the rheumatic diseases. 2019.

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

Wu W.; Jordan S.; Graf N.; de Oliveira Pena J.; Curram J.; Allanore Y.; Matucci-Cerinic M.; Pope J.E.; Denton C.P.; Khanna D.; Distler O.; Guiducci S.; Walker U.; Jaeger V.; Bannert B.; Lapadula G.; Becvarare R.; Cutolo M.; Valentini G.; Siegert E.; Rednic S.; Montecucco C.; Carreira P.E.; Novak S.; Czirjak L.; Varju C.; Chizzolini C.; Allai D.; Kucharz E.J.; Cozzi F.; Rozman B.; Mallia C.; Gabrielli A.; Bancel D.F.; Airo P.; Hesselstrand R.; Martinovic D.; Balbir-Gurman A.; Braun-Moscovici Y.; Hunzelmann N.; Pellerito R.; Caramaschi P.; Black C.; Damjanov N.; Henes J.; Santamaria V.O.; Heitmann S.; Seidel M.; Pereira Da Silva J.A.; Stamenkovic B.; Selmi C.F.; Tikly M.; Denisov L.N.; Muller-Ladner U.; Engelhart M.; Hachulla E.; Riccieri V.; Ionescu R.M.; Mihai C.; Sunderkotter C.; Kuhn A.; Schett G.; Distler J.; Meroni P.; Ingegnoli F.; Mouthon L.; De Keyser F.; Smith V.; Cantatore F.P.; Corrado A.; Ullman S.; Iversen L.; Pozzi M.R.; Eyerich K.; Hein R.; Knott E.; Wiland P.; Szmyrka-Kaczmarek M.; Sokolik R.; Morgiel E.; Madej M.; Alegre-Sancho J.J.; Krummel-Lorenz B.; Saar P.; Aringer M.; Gunther C.; Anne E.; Westhovens R.; De Langhe E.; Lenaerts J.; Anic B.; Baresic M.; Mayer M.; Uprus M.; Otsa K.; Yavuz S.; Radominski S.C.; de Souza Muller C.; Azevedo V.F.; Popa S.; Zenone T.; Stebbings S.; Highton J.; Mathieu A.; Vacca A.; Stamp L.; Chapman P.; O'donnell J.; Solanki K.; Doube A.; Veale D.; O'rourke M.; Loyo E.; Li M.; Rosato E.; Amoroso A.; Gigante A.; Oksel F.; Yargucu F.; Tanaseanu C.-M.; Popescu M.; Dumitrascu A.; Tiglea I.; Foti R.; Visalli E.; Benenati A.; Amato G.; Ancuta C.; Chirieac R.; Villiger P.; Adler S.; Dan D.; de la Pena Lefebvre P.G.; Rubio S.R.; Exposito M.V.; Sibilia J.; Chatelus E.; Gottenberg J.E.; Chifflot H.; Litinsky I.; Del Galdo F.; Venalis A.; Saketkoo L.A.; Lasky J.A.; Kerzberg E.; Montoya F.; Cosentino V.; Limonta M.; Brucato A.L.; Lupi E.; Spertini F.; Ribi C.; Buss G.; Martin T.; Guffroy A.; Poindron V.; Chung L.; Schmeiser T.; Zebryk P.; Riso N.; Riemekasten G.; Rezus E.; Sarzi Puttini P.. Annals of the rheumatic diseases. 2019.

Raynaud's phenomenon: no net effects of vasodilators in a network analysis

Jaeger V.K.; Walker U.A.. Lancet Rheumatology. 2019.

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual

Fasano S.; Riccardi A.; Messiniti V.; Caramaschi P.; Rosato E.; Maurer B.; Smith V.; Siegert E.; De Langhe E.; Riccieri V.; Airo P.; Mihai C.; Avouac J.; Zanatta E.; Walker U.A.; Iannone F.; Garcia De La Pena Lefebvre P.; Distler J.H.W.; Vacca A.; Distler O.; Kowal-Bielecka O.; Allanore Y.; Valentini G.. Annals of the rheumatic diseases. 2019.

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: A cross-sectional study

Osthoff M.; Jaeger V.K.; Heijnen I.A.F.M.; Trendelenburg M.; Jordan S.; Distler O.; Walker U.A.. Arthritis Research and Therapy. 2019.

Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study

Buhler S.; Jaeger V.K.; Adler S.; Bannert B.; Brummerhoff C.; Ciurea A.; Distler O.; Franz J.; Gabay C.; Hagenbuch N.; Herzog C.; Hasler P.; Kling K.; Kyburz D.; Muller R.; Nissen M.J.; Siegrist C.-A.; Villiger P.M.; Walker U.A.; Hatz C.. Rheumatology (United Kingdom). 2019.

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study

Valentini G.; Huscher D.; Riccardi A.; Fasano S.; Irace R.; Messiniti V.; Matucci-Cerinic M.; Guiducci S.; Distler O.; Maurer B.; Avouac J.; Tarner I.H.; Frerix M.; Riemekasten G.; Siegert E.; Czirjak L.; Lorand V.; Denton C.P.; Nihtyanova S.; Walker U.A.; Jaeger V.K.; Del Galdo F.; Abignano G.; Ananieva L.P.; Gherghe A.M.; Mihai C.; Henes J.C.; Schmeiser T.; Vacca A.; Moiseev S.; Foeldvari I.; Gabrielli A.; Krummel-Lorenz B.; Rednic S.; Allanore Y.; Mueller-Ladner U.. Annals of the rheumatic diseases. 2019.

Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.

Jaeger VK; Valentini G; Hachulla E; Cozzi F; Distler O; Airó P; Czirják L; Allanore Y; Siegert E; Rosato E; Matucci-Cerinic M; Caimmi C; Henes J; Carreira PE; Smith V; Del Galdo F; Denton CP; Ullman S; De Langhe E; Riccieri V; Alegre-Sancho JJ; Rednic S; Müller-Ladner U; Walker UA; EUSTAR coauthors.. Arthritis and Rheumatology. 2018.

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

Beyer C; Huscher D; Ramming A; Bergmann C; Avouac J; Guiducci S; Meier F; Vettori S; Siegert E; Jaeger VK; Maurer B; Riemekasten G; Walker U; Müller-Ladner U; Valentini G; Matucci-Cerinic M; Allanore Y; Distler O; Schett G; Distler JHW. Annals of the rheumatic diseases. 2018.

Flare of a Cryopyrin-associated Periodic Syndrome Following Vaccination with Neisseria Meningitidis Polysaccharides.

Walker UA; Luetke Volksbeck S; Kuemmerle-Deschner J. Journal of Rheumatology. 2018.

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

Jaeger VK; Distler O; Maurer B; Czirják L; Lóránd V; Valentini G; Vettori S; Del Galdo F; Abignano G; Denton C; Nihtyanova S; Allanore Y; Avouac J; Riemekasten G; Siegert E; Huscher D; Matucci-Cerinic M; Guiducci S; Frerix M; Tarner IH; Garay Toth B; Fankhauser B; Umbricht J; Zakharova A; Mihai C; Cozzi F; Yavuz S; Hunzelmann N; Rednic S; Vacca A; Schmeiser T; Riccieri V; García de la Peña Lefebvre P; Gabrielli A; Krummel-Lorenz B; Martinovic D; Ancuta C; Smith V; Müller-Ladner U; Walker UA. Rheumatology (United Kingdom). 2018.

Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.

Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y; the EUSTAR co-authors.. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2018.

Haematopoietic stem cell transplantation in systemic sclerosis.

Walker UA; Saketkoo LA; Distler O. RMD open. 2018.

Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study.

Walker UA; Jaeger VK; Bruppacher KM; Dobrota R; Arlettaz L; Banyai M; Beron J; Chizzolini C; Groechenig E; Mueller RB; Spertini F; Villiger PM; Distler O. Arthritis research & therapy. 2018.

Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.

Adler S; Huscher D; Siegert E; Allanore Y; Czirják L; DelGaldo F; Denton CP; Distler O; Frerix M; Matucci-Cerinic M; Mueller-Ladner U; Tarner IH; Valentini G; Walker UA; Villiger PM; Riemekasten G; EUSTAR co-workers on behalf of the DeSScipher project research group within the EUSTAR network.. Arthritis research & therapy. 2018.

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Johnson SR; Soowamber ML; Fransen J; Khanna D; Van Den Hoogen F; Baron M; Matucci-Cerinic M; Denton CP; Medsger TA Jr; Carreira PE; Riemekasten G; Distler J; Gabrielli A; Steen V; Chung L; Silver R; Varga J; Müller-Ladner U; Vonk MC; Walker UA; Wollheim FA; Herrick A; Furst DE; Czirjak L; Kowal-Bielecka O; Del Galdo F; Cutolo M; Hunzelmann N; Murray CD; Foeldvari I; Mouthon L; Damjanov N; Kahaleh B; Frech T; Assassi S; Saketkoo LA; Pope JE. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018.

CLASSIFICATION, CATEGORISATION AND ESSENTIAL ITEMS FOR DIGITAL ULCER (DU) EVALUATION IN SYSTEMIC SCLEROSIS (SSC): A DESSCIPHER/EUSTAR SURVEY

Blagojevic, J.; Cometi, L.; Abignano, G.; Guiducci, S.; Bellando-Randone, S.; Huscher, D.; Avouac, J.; Czirjak, L.; Denton, C.; Distler, O.; Frerix, M.; Jaeger, V. K.; Lorand, V.; Maurer, B.; Nihtyanova, S.; Riemekasten, G.; Siegert, E.; Valentini, G.; Vettori, S.; Walker, U.; Mueller-Ladner, U.; Allanore, Y.; Del Galdo, F.; Matucci-Cerinic, M.. Annals of the rheumatic diseases. 2017.

Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis.

Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Allanore Y; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Matucci-Cerinic M; and EUSTAR co-authors.. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2017.

Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp.

Walker UA; Mueller RB; Jaeger VK; Theiler R; Forster A; Dufner P; Ganz F; Kyburz D. Rheumatology (United Kingdom). 2017.

Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis.

Alpizar-Rodriguez D; Mueller RB; Möller B; Dudler J; Ciurea A; Zufferey P; Kyburz D; Walker UA; von Mühlenen I; Roux-Lombard P; Mahler M; Lamacchia C; Courvoisier DS; Gabay C; Finckh A. Rheumatology (United Kingdom). 2017.

FREQUENT, UNUSUALLY SEVERE, LONG LASTING, LOCAL AND SYSTEMIC PNEUMOCOCCAL VACCINE REACTIONS IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS): RESULTS OF A PROSPECTIVE REGISTRY BASED STUDY

Jaeger, V. K.; Hoffmann, H. M.; van der Poll, T.; Tilson, H.; Seibert, J.; Speziale, A.; Junge, G.; Franke, K.; Vritzali, E.; Hawkins, P. N.; Kuemmerle-Deschner, J.; Walker, U. A.. Annals of the rheumatic diseases. 2017.

Mapping and predicting mortality from systemic sclerosis.

Elhai M; Meune C; Boubaya M; Avouac J; Hachulla E; Balbir-Gurman A; Riemekasten G; Airò P; Joven B; Vettori S; Cozzi F; Ullman S; Czirják L; Tikly M; Müller-Ladner U; Caramaschi P; Distler O; Iannone F; Ananieva LP; Hesselstrand R; Becvar R; Gabrielli A; Damjanov N; Salvador MJ; Riccieri V; Mihai C; Szücs G; Walker UA; Hunzelmann N; Martinovic D; Smith V; Müller CS; Montecucco CM; Opris D; Ingegnoli F; Vlachoyiannopoulos PG; Stamenkovic B; Rosato E; Heitmann S; Distler JHW; Zenone T; Seidel M; Vacca A; Langhe E; Novak S; Cutolo M; Mouthon L; Henes J; Chizzolini C; Mühlen CAV; Solanki K; Rednic S; Stamp L; Anic B; Santamaria VO; De Santis M; Yavuz S; Sifuentes-Giraldo WA; Chatelus E; Stork J; Laar JV; Loyo E; García de la Peña Lefebvre P; Eyerich K; Cosentino V; Alegre-Sancho JJ; Kowal-Bielecka O; Rey G; Matucci-Cerinic M; Allanore Y; EUSTAR group.. Annals of the rheumatic diseases. 2017.

Mitochondrial DNA Mutations and Respiratory Chain Dysfunction in Lung Fibrosis of Systemic Sclerosis

Jaeger, Veronika K.; Lebrecht, Dirk; Nicholson, Andrew G.; Wells, Athol U.; George, Suresh; Gazdhar, Amiq; Tamm, Michael; Venhoff, Nils; Geiser, Thomas; Walker, Ulrich A.. Arthritis and Rheumatology. 2017.

Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Walker UA; Clements PJ; Allanore Y; Distler O; Oddis CV; Khanna D; Furst DE. Rheumatology (United Kingdom). 2017.

Myositis in Systemic Sclerosis, Lupus Erythematosus and Sjogren's Syndrome

Keck, A. D.; Jaeger, V. K.; Walker, U. A.. AKTUELLE RHEUMATOLOGIE. 2017.

Patient's Self-Monitoring of Disease Activity of Rheumatic Diseases Via Webapp - Study Design, Patient's Perspective and Recruitment in the First 16 Months of a Swiss Multicentre, Longitudinal Study

Jaeger, Veronika K.; Barmet, Anna; Schiffer, Pia; Zufferey, Pascal; Badaracco, Andrea; Walder, Marcel; Dudler, Jean; Frey, Dieter; Mueller, Franziska; Pichler, Lilian; Voss, Peter; Bosia, Lorenzo; Walker, Ulrich A.. Arthritis and Rheumatology. 2017.

Pharmacological treatment options for cryopyrin-associated periodic syndromes.

Landmann EC; Walker UA. Expert Review of Clinical Pharmacology. 2017.

Points to consider when doing a trial primarily involving the heart.

Allanore Y; Distler O; Walker UA; Khanna D; Furst DE; Meune C. Rheumatology (United Kingdom). 2017.

PROSPECTIVE EVALUATION OF THE CAPILLAROSCOPIC SKIN ULCER INDEX (CSURI) IN CLINICAL PRACTICE

Walker, U. A.; Jaeger, V. K.; Arlettaz, L.; Banyai, M.; Beron, J.; Chizzolini, C.; Groechenig, E.; Mueller, R. B.; Spertini, F.; Villiger, P.; Distler, O.. Annals of the rheumatic diseases. 2017.

Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study.

Jaeger VK; Hoffman HM; van der Poll T; Tilson H; Seibert J; Speziale A; Junge G; Franke K; Vritzali E; Hawkins PN; Kuemmerle-Deschner J; Walker UA. Rheumatology (United Kingdom). 2017.

SMOKING BEHAVIOUR AND THE PROGRESSION OF ORGAN MANIFESTATIONS IN SYSTEMIC SCLEROSIS: A LONGITUDINAL EUROPEAN SCLERODERMA TRIALS AND RESEARCH GROUP STUDY

Jaeger, V. K.; Valentini, G.; Hachulla, E.; Czirjak, L.; Siegert, E.; Distler, O.; Bambara, L. M.; Rosato, E.; Allanore, Y.; Matucci-Cerinic, M.; Airo, P.; Walker, U.. Annals of the rheumatic diseases. 2017.

The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.

Valentini G; Iudici M; Walker UA; Jaeger VK; Baron M; Carreira P; Czirják L; Denton CP; Distler O; Hachulla E; Herrick AL; Kowal-Bielecka O; Pope J; Müller-Ladner U; Riemekasten G; Avouac J; Frerix M; Jordan S; Minier T; Siegert E; Ong VH; Vettori S; Allanore Y. Annals of the rheumatic diseases. 2017.

The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.

Alpizar-Rodriguez D; Brulhart L; Mueller RB; Möller B; Dudler J; Ciurea A; Walker UA; Von Mühlenen I; Kyburz D; Zufferey P; Mahler M; Bas S; Gascon D; Lamacchia C; Roux-Lombard P; Lauper K; Nissen MJ; Courvoisier DS; Gabay C; Finckh A. CLINICAL RHEUMATOLOGY. 2017.

Trial of Tocilizumab in Giant-Cell Arteritis.

Walker UA. The New England journal of medicine. 2017.

Update of EULAR recommendations for the treatment of systemic sclerosis.

Kowal-Bielecka O; Fransen J; Avouac J; Becker M; Kulak A; Allanore Y; Distler O; Clements P; Cutolo M; Czirjak L; Damjanov N; Del Galdo F; Denton CP; Distler JHW; Foeldvari I; Figelstone K; Frerix M; Furst DE; Guiducci S; Hunzelmann N; Khanna D; Matucci-Cerinic M; Herrick AL; van den Hoogen F; van Laar JM; Riemekasten G; Silver R; Smith V; Sulli A; Tarner I; Tyndall A; Welling J; Wigley F; Valentini G; Walker UA; Zulian F; Müller-Ladner U; EUSTAR Coauthors.. Annals of the rheumatic diseases. 2017.

A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.

Elhai M; Avouac J; Walker UA; Matucci-Cerinic M; Riemekasten G; Airò P; Hachulla E; Valentini G; Carreira PE; Cozzi F; Balbir Gurman A; Braun-Moscovici Y; Damjanov N; Ananieva LP; Scorza R; Jimenez S; Busquets J; Li M; Müller-Ladner U; Kahan A; Distler O; Allanore Y; EUSTAR co-authors.. Annals of the rheumatic diseases. 2016.

Brief Report: Severe Inflammation Following Vaccination Against Streptococcus pneumoniae in Patients With Cryopyrin-Associated Periodic Syndromes.

Walker UA; Hoffman HM; Williams R; Kuemmerle-Deschner J; Hawkins PN. Arthritis and Rheumatology. 2016.

Digital ulcers predict a worse disease course in patients with systemic sclerosis.

Mihai C; Landewé R; van der Heijde D; Walker UA; Constantin PI; Gherghe AM; Ionescu R; Rednic S; Allanore Y; Avouac J; Czirják L; Hachulla E; Riemekasten G; Cozzi F; Airò P; Cutolo M; Mueller-Ladner U; Matucci-Cerinic M; EUSTAR co-authors.. Annals of the rheumatic diseases. 2016.

Effect of endothelin-1 receptor antagonists on skin fibrosis in scleroderma patients from the EUSTAR database

Jordan S.; Distler J.; Maurer B.; Walker U.A.; Huscher D.; Allanore Y.; Riemekasten G.; Distler O.. Journal of Scleroderma and Related Disorders. 2016.

Erectile Dysfunction in Systemic Sclerosis.

Jaeger VK; Walker UA. Current Rheumatology Reports. 2016.

Immunomodulation of rheumatologic disorders with non-biologic disease modifying antirheumtic drugs.

Walker UA. SEMINARS IN HEMATOLOGY. 2016.

Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.

Wirz EG; Jaeger VK; Allanore Y; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Tikly M; Vettori S; Balbir Gurman A; Damjanov N; Müller-Ladner U; Distler J; Li M; Häusermann P; Walker UA; EUSTAR coauthors.. Annals of the rheumatic diseases. 2016.

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.

Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA; EUSTAR co-authors.. PLoS One. 2016.

Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study.

Avouac J; Walker UA; Hachulla E; Riemekasten G; Cuomo G; Carreira PE; Caramaschi P; Ananieva LP; Matucci-Cerinic M; Czirjak L; Denton C; Ladner UM; Allanore Y; EUSTAR collaborators*.; EUSTAR collaborators.. Annals of the rheumatic diseases. 2016.

Pyoderma Gangrenosum and Erythema Nodosum Revealing Takayasu's Arteritis.

Loetscher J; Fistarol S; Walker UA. Case reports in dermatology. 2016.

Quantitative dynamic contrast-enhanced ultrasound for the functional evaluation of the skeletal muscle microcirculation in systemic sclerosis.

Partovi S; Kaspar M; Aschwanden M; Robbin MR; Bilecen D; Walker UA; Staub D. Clinical hemorheology and microcirculation. 2016.

Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis.

Walker UA; Jaeger VK; Chatzidionysiou K; Hetland ML; Hauge EM; Pavelka K; Nordström DC; Canhão H; Tomšič M; van Vollenhoven R; Gabay C. Rheumatology (United Kingdom). 2016.

[Common German language nomenclature for systemic sclerosis].

Aringer M; Müller-Ladner U; Burkhardt H; Distler JH; Distler O; Graninger WB; Günther C; Hunzelmann N; Kiener H; Sticherling M; Sunderkötter C; Walker UA; Riemekasten G. ZEITSCHRIFT FUR RHEUMATOLOGIE. 2015.

A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study

Ingegnoli F.; Boracchi P.; Gualtierotti R.; Smith V.; Cutolo M.; Foeldvari I.; Airo P.; Alegre-Sancho J.J.; Allanore Y.; Ananieva L.P.; Ancuta C.; Andrade L.E.; Aringer M.; Becvar R.; Bojinca M.; Butrimiene I.; Cantatore F.P.; Caporali R.; Caramaschi P.; Carreira P.E.; Chirieac R.; Corrado A.; Cosentino V.; Cuomo G.; Czirjak L.; Da Silva J.A.P.; de la Pena Lefebvre P.G.; De Keyser F.; de Souza Muller C.; Damgaard K.; Damjanov N.; Denisov L.N.; Distler O.; Doube A.; Dumitrascu A.; Engelhart M.; Exposito M.V.; Eyerich K.; Farge-Bancel D.; Azevedo V.F.; Foti R.; Frerix M.; Gabrielli A.; Garen T.; Gottschalk P.; Groseanu L.; Guiducci S.; Gunther C.; Hachulla E.; Hein R.; Heitmann S.; Henes J.; Hesselstrand R.; Highton J.; Iannone F.; Ionescu R.M.; Kayser C.; Karpec D.; Kerzberg E.; Kotulska A.; Kopec-Medrek M.; Kucharz E.; Krummel-Lorenz B.; Lauffer F.; Launay D.; Li M.; Litinsky I.; Loyo E.; Cerinic M.M.; Meroni P.; Midtvedt O.; Mihai C.M.; Montecucco C.; Montoya F.; Morgiel E.; Mouthon L.; Muller-Ladner U.; Nielsen H.; Opris D.; Ortiz-Santamaria V.; Otsa K.; Pileckyte M.; Pisarri S.; Popescu M.; Pozzi M.R.; Puppo F.; Radominski S.C.; Riccieri V.; Rosato E.; Rozman B.; Rubio S.R.; Rugiene R.; Saar P.; Salvador M.J.; Seidel M.; Sokolik R.; Solanki K.; Stamenkovic B.; Stankovic A.; Stebbings S.; Strauss G.; Sulli A.; Szamosi S.; Szechinski J.; Szmyrka-Kaczmarek M.; Szucs G.; Tanaseanu C.-M.; Tiglea I.; Tyndall A.; Ughi N.; Uprus M.; Vacca A.; Varju C.; Venalis A.; Venalis P.; Walker U.A.; Widuchowska M.; Wiland P.; M. Wuttge D.; Zeni S.; Zenone T.. MICROVASCULAR RESEARCH. 2015.

An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database.

Brand M; Hollaender R; Rosenberg D; Scott M; Hunsche E; Tyndall A; Denaro V; Carreira P; Varju C; Gabrielli B; Zingarelli S; Caramaschi P; Simic-Pasalic K; Müller-Ladner U; Vasile M; Mihai C; Rosato E; Vacca A; Zenone T; Mohamed WA; Ancuta C; Zampogna G; Rednic S; Jabaar N; Belloli L; Pozzi MR; Foti R; Walker UA; EUSTAR Co-Investigators.. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015.

Assessment of cutaneous microcirculation in unaffected skin regions by transcutaneous oxygen saturation monitoring and Laser Doppler flowmetry in systemic sclerosis.

Broz P; Aschwanden M; Partovi S; Schulte AC; Benz D; Takes M; Walker UA; Bilecen D; Jaeger KA; Staub D. Clinical hemorheology and microcirculation. 2015.

Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database

Sandmeier, B.; Jaeger, V. K.; Nagy, G.; Carreira, P. E.; Tzankov, A.; Widuchowska, M.; Antic, M.; Distler, O.; Reichert, H.; Distler, J. H. W.; Walker, U. A.; Huegle, T.. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015.

Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group

Jordan S.; Distler J.H.W.; Maurer B.; Huscher D.; Van Laar J.M.; Allanore Y.; Distler O.; Kvien T.K.; Airo P.; Sancho J.J.A.; Ananjeva L.; Ancuta C.M.; Aringer M.; Balbir-Gurman A.; Cantatore F.P.; Caramaschi P.; Chatelus E.; Codullo V.; Farge-Bancel D.; Foti R.; Gabrielli A.; Henes J.; Herrgott I.; Iannone F.; Ingegnoli F.; Loyo E.; Matucci-Cerinic M.; Mohamed W.A.A.A.; Muller-Ladner U.; Palm O.; Popa S.; Riemekasten G.; Rednic S.; Rosato E.; Saracco M.; Scheja A.; Smith V.; Mihai C.; Szucs G.; Tomsic M.; Valentini G.; Walker U.A.; Westhovens R.; Yavuz S.K.; Zenone T.. Annals of the rheumatic diseases. 2015.

Magnetic Resonance Imaging-Confirmed Pleuritis in Systemic Lupus Erythematosus-Associated Shrinking Lung Syndrome.

Nemec M; Pradella M; Jahn K; Tamm M; Walker UA. Arthritis and Rheumatology. 2015.

Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database

Maurer B.; Graf N.; Michel B.A.; Muller-Ladner U.; Czirjak L.; Denton C.P.; Tyndall A.; Metzig C.; Lanius V.; Khanna D.; Distler O.; Tarner I.H.; Cerinic M.M.; Guiducci S.; Walker U.; Lapadula G.; Iannone F.; Becvar R.; Sierakowsky S.; Bielecka O.K.; Cutolo M.; Sulli A.; Valentini G.; Cuomo G.; Vettori S.; Riemekasten G.; Rednic S.; Nicoara I.; Kahan A.; Allanore Y.; Vlachoyiannopoulos P.; Montecucco C.; Caporali R.; Carreira P.E.; Novak S.; Varju C.; Chizzolini C.; Kucharz E.J.; Kotulska A.; Kopec-Medrek M.; Widuchowska M.; Cozzi F.; Rozman B.; Mallia C.; Coleiro B.; Gabrielli A.; Farge D.; Hij A.; Airo P.; Hesselstrand R.; Scheja A.; Wollheim F.; Martinovic D.; Gurman A.B.; Braun-Moscovici Y.; Govoni M.; Monaco A.L.; Hunzelmann N.; Pellerito R.; Bambara L.M.; Caramaschi P.; Black C.; Damjanov N.; Henes J.; Santamaria V.O.; Heitmann S.; Krasowska D.; Seidel M.; Oleszowsky M.; Burkhardt H.; Himsel A.; Salvador M.J.; Stamenkovic B.; Stankovic A.; Tikly M.; Starovoytova M.N.; Ananieva L.P.; Scorza R.; Engelhart M.; Strauss G.; Nielsen H.; Damgaard K.; Szucs G.; Mendoza A.Z.; de la Puente Buijdos C.; Sifuentes Giraldo W.A.; Midtvedt O.; Garen T.; Hachulla E.; Launay D.; Valesini G.; Riccieri V.; Ionescu R.M.; Opris D.; Groseanu L.; Wigley F.M.; Mihai C.M.; Cornateanu R.S.; Ionitescu R.; Gherghe A.M.; Gorga M.; Dobrota R.; Bojinca M.; Schett G.; Distler J.H.W.; Meroni P.; Zeni S.; Mouthon L.; De Keyser F.; Smith V.; Cantatore F.P.; Corrado A.; Ullman S.; Iversen L.; Pozzi M.R.; Eyerich K.; Hein R.; Knott E.; Szechinski J.; Wiland P.; Szmyrka-Kaczmarek M.; Sokolik R.; Morgiel E.; Krummel-Lorenz B.; Saar P.; Aringer M.; Gunther C.; Anic B.; Baresic M.; Mayer M.; Radominski S.C.; de Souza Muller C.; Azevedo V.F.; Agachi S.; Groppa L.; Chiaburu L.; Russu E.; Zenone T.; Stebbings S.; Highton J.; Stamp L.; Chapman P.; O'Donnell J.; Solanki K.; Doube A.; Veale D.; O'Rourke M.; Loyo E.; Li M.; Rosato E.; Pisarri S.; Tanaseanu C.-M.; Popescu M.; Dumitrascu A.; Tiglea I.; Chirieac R.; Ancuta C.; Furst D.E.; Kafaja S.; de la Pena Lefebvre P.G.; Rubio S.R.; Exposito M.V.; Sibilia J.; Chatelus E.; Gottenberg J.E.; Chifflot H.; Litinsky I.; Venalis A.; Butrimiene I.; Venalis P.; Rugiene R.; Karpec D.; Kerzberg E.; Montoya F.; Cosentino V.. Annals of the rheumatic diseases. 2015.

Role of MRI in diagnosis and management of idiopathic inflammatory myopathies.

Maurer B; Walker UA. Current Rheumatology Reports. 2015.

The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement.

Aschwanden M; Imfeld S; Staub D; Baldi T; Walker UA; Berger CT; Hess C; Daikeler T. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015.

Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards.

Khanna D; Furst DE; Allanore Y; Bae S; Bodukam V; Clements PJ; Cutolo M; Czirjak L; Denton CP; Distler O; Walker UA; Matucci-Cerinic M; Müller-Ladner U; Seibold JR; Singh M; Tyndall A. Rheumatology (United Kingdom). 2015.

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.

Hachulla E; Clerson P; Airò P; Cuomo G; Allanore Y; Caramaschi P; Rosato E; Carreira PE; Riccieri V; Sarraco M; Denton CP; Riemekasten G; Pozzi MR; Zeni S; Mihai CM; Ullman S; Distler O; Rednic S; Smith V; Walker UA; Matucci-Cerinic M; Müller-Ladner U; Launay D; EUSTAR co-workers.. Rheumatology (United Kingdom). 2015.

Biological agents in monotherapy for the treatment of rheumatoid arthritis.

Gabay C; Hasler P; Kyburz D; So A; Villiger P; von Kempis J; Walker U. Schweizerische Medizinische Wochenschrift. 2014.

Correlation of skeletal muscle blood oxygenation level-dependent MRI and skin laser Doppler flowmetry in patients with systemic sclerosis.

Partovi S; Schulte AC; Staub D; Jacobi B; Aschwanden M; Walker UA; Imfeld S; Broz P; Benz D; Zipp L; Takes M; Jäger KA; Huegli RW; Bilecen D. Journal of magnetic resonance imaging : JMRI. 2014.

Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: Analysis of underlying signal transduction pathways and potential diagnostic utility

Sur Chowdhury C.; Giaglis S.; Walker U.A.; Buser A.; Hahn S.; Hasler P.. Arthritis Research and Therapy. 2014.

Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.

Johnson SR; Naden RP; Fransen J; van den Hoogen F; Pope JE; Baron M; Tyndall A; Matucci-Cerinic M; Denton CP; Distler O; Gabrielli A; van Laar JM; Mayes M; Steen V; Seibold JR; Clements P; Medsger TA Jr; Carreira PE; Riemekasten G; Chung L; Fessler BJ; Merkel PA; Silver R; Varga J; Allanore Y; Mueller-Ladner U; Vonk MC; Walker UA; Cappelli S; Khanna D. Journal of clinical epidemiology. 2014.

Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysis.

Keck AD; Foocharoen C; Rosato E; Smith V; Allanore Y; Distler O; Stamenkovic B; Pereira Da Silva JA; Hadj Khelifa S; Denisov LN; Hachulla E; García de la Peña Lefebvre P; Sibilia J; Airò P; Caramaschi P; Müller-Ladner U; Wiland P; Walker UA. Rheumatology (United Kingdom). 2014.

Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.

Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; EUSTAR co-workers.; EUSTAR co-workers.. Annals of the rheumatic diseases. 2014.

Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.

Ghrénassia E; Avouac J; Khanna D; Derk CT; Distler O; Suliman YA; Airo P; Carreira PE; Foti R; Granel B; Berezne A; Cabane J; Ingegnoli F; Rosato E; Caramaschi P; Hesselstrand R; Walker UA; Alegre-Sancho JJ; Zarrouk V; Agard C; Riccieri V; Schiopu E; Gladue H; Steen VD; Allanore Y. Journal of Rheumatology. 2014.

Time-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosis

Gazdhar A.; Lebrecht D.; Roth M.; Tamm M.; Venhoff N.; Foocharoen C.; Geiser T.; Walker U.A.. Scientific Reports. 2014.

Zidovudine induces visceral mitochondrial toxicity and intra-abdominal fat gain in a rodent model of lipodystrophy

Walker, Ulrich A.; Lebrecht, Dirk; Reichard, Wilfried; Kirschner, Janbernd; Bisse, Emmanuel; Iversen, Line; Venhoff, Ana C.; Venhoff, Nils. Antiviral therapy. 2014.

[Therapy of myositis].

Keck AD; Walker UA. ZEITSCHRIFT FUR RHEUMATOLOGIE. 2013.

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA Jr; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE. Annals of the rheumatic diseases. 2013.

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA Jr; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Csuka ME; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE. Arthritis and rheumatism. 2013.

Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: A EUSTAR group-based study

Heijnen I.A.F.M.; Foocharoen C.; Bannert B.; Carreira P.E.; Caporali R.; Smith V.; Kumanovics G.; Becker M.O.; Vanthuyne M.; Simsek I.; Bocelli-Tyndall C.; Walker U.A.. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013.

Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.

Heijnen IA; Foocharoen C; Bannert B; Carreira PE; Caporali R; Smith V; Kumánovics G; Becker MO; Vanthuyne M; Simsek I; Bocelli-Tyndall C; Walker UA. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013.

Correlation of muscle BOLD MRI with transcutaneous oxygen pressure for assessing microcirculation in patients with systemic sclerosis.

Partovi S; Aschwanden M; Jacobi B; Schulte AC; Walker UA; Staub D; Imfeld S; Broz P; Benz D; Zipp L; Jaeger KA; Takes M; Robbin MR; Huegli RW; Bilecen D. Journal of magnetic resonance imaging : JMRI. 2013.

Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry.

Tilson H; Primatesta P; Kim D; Rauer B; Hawkins PN; Hoffman HM; Kuemmerle-Deschner J; van der Poll T; Walker UA. Orphanet Journal of Rare Diseases. 2013.

Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis.

Kollert F; Christoph S; Probst C; Budweiser S; Bannert B; Binder M; Sehnert B; Voll RE; Warnatz K; Zissel G; Walker UA; Prasse A; Saalbach A. ARTHRITIS CARE & RESEARCH. 2013.

Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database

Schneeberger, Daniel; Tyndall, Alan; Kay, Jonathan; Sondergaard, Klaus H.; Carreira, Patricia E.; Morgiel, Ewa; Deuschle, Katrin; Derk, Chris T.; Widuchowska, Malgorzata; Walker, Ulrich A.. Rheumatology (United Kingdom). 2013.

Antiretroviral nucleoside analogues suppress antibody synthesis in human B-lymphocytes.

Setzer B; Walker UA. Antiviral therapy. 2012.

Changes in Inflammation, Oxidative Stress, Mitochondrial DNA Content after Rosiglitazone in HIV Lipoatrophy.

Tungsiripat M; El-Bejjani D; Rizk N; Hu B; Ross AC; Walker UA; Lebrecht D; Milne G; Storer N; McComsey GA. Journal of AIDS & clinical research. 2012.

Clinical correlations of hypocomplementaemia in systemic sclerosis: an analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) database.

Foocharoen C; Distler O; Becker M; Müller-Ladner U; von Mühlen C; Leuchten N; Walker UA. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2012.

Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis.

Binder M; Uhl M; Wiech T; Kollert F; Thiel J; Sass JO; Walker UA; Peter HH; Warnatz K. Annals of the rheumatic diseases. 2012.

Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress.

Ross AC; Leong T; Avery A; Castillo-Duran M; Bonilla H; Lebrecht D; Walker UA; Storer N; Labbato D; Khaitan A; Tomanova-Soltys I; McComsey GA. HIV Medicine. 2012.

Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: A study of the EULAR Scleroderma Trial and Research group

Foocharoen C.; Tyndall A.; Hachulla E.; Rosato E.; Allanore Y.; Farge-Bancel D.; Caramaschi P.; Airo P.; Starovojtova M.N; Pereira da Silva J.A.; Stamenkovic B.; Riemekasten G.; Rednic S.; Sibilia J.; Wiland P.; Tarner I.; Smith V.; Onken A.T.; Abdel Atty Mohamed W.A.; Distler O.; Morovic-Vergles J.; Himsel A.; de la Pena Lefebvre P.G.; Hugle T.; Walker U.A.. Arthritis Research and Therapy. 2012.

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists.

Finckh,Axel; Möller,Burkhard; Dudler,Jean; Walker,Ulrich A; Kyburz,Diego; Gabay,Cem; physicians of the Swiss Clinical Quality Management for Rheumatoid Arthritis; physicians of SCQM-RA. Annals of the rheumatic diseases. 2012.

Impaired skeletal muscle microcirculation in systemic sclerosis.

Partovi S; Schulte AC; Aschwanden M; Staub D; Benz D; Imfeld S; Jacobi B; Broz P; Jäger KA; Takes M; Huegli RW; Bilecen D; Walker UA. Arthritis research & therapy. 2012.

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.

Fransen J; Johnson SR; van den Hoogen F; Baron M; Allanore Y; Carreira PE; Czirják L; Denton CP; Distler O; Furst DE; Gabrielli A; Herrick A; Inanc M; Kahaleh B; Kowal-Bielecka O; Medsger TA Jr; Mueller-Ladner U; Riemekasten G; Sierakowski S; Valentini G; Veale D; Vonk MC; Walker U; Chung L; Clements PJ; Collier DH; Csuka ME; Jimenez S; Merkel PA; Seibold JR; Silver R; Steen V; Tyndall A; Matucci-Cerinic M; Pope JE; Khanna D. ARTHRITIS CARE & RESEARCH. 2012.

Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy.

Venhoff N; Lebrecht D; Pfeifer D; Venhoff AC; Bissé E; Kirschner J; Walker UA. Arthritis research & therapy. 2012.

Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behcet's disease following 23-valent polysaccharide Streptococcus pneumoniae vaccine.

Hügle T; Bircher A; Walker UA. Rheumatology (United Kingdom). 2012.

TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients.

Koumakis E; Wipff J; Dieudé P; Ruiz B; Bouaziz M; Revillod L; Guedj M; Distler JH; Matucci-Cerinic M; Humbert M; Riemekasten G; Airo P; Melchers I; Hachulla E; Cusi D; Wichmann HE; Hunzelmann N; Tiev K; Caramaschi P; Diot E; Kowal-Bielecka O; Cuomo G; Walker U; Czirják L; Damjanov N; Lupoli S; Conti C; Müller-Nurasyid M; Müller-Ladner U; Riccieri V; Cracowski JL; Cozzi F; Bournia VK; Vlachoyiannopoulos P; Chiocchia G; Boileau C; Allanore Y. Annals of the rheumatic diseases. 2012.

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis.

Fuchs M; Briel M; Daikeler T; Walker UA; Rasch H; Berg S; Ng QK; Raatz H; Jayne D; Kötter I; Blockmans D; Cid MC; Prieto-González S; Lamprecht P; Salvarani C; Karageorgaki Z; Watts R; Luqmani R; Müller-Brand J; Tyndall A; Walter MA. European journal of nuclear medicine and molecular imaging. 2012.

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.

Meier,Florian M P; Frommer,Klaus W; Dinser,Robert; Walker,Ulrich A; Czirjak,Laszlo; Denton,Christopher P; Allanore,Yannick; Distler,Oliver; Riemekasten,Gabriela; Valentini,Gabriele; Müller-Ladner,Ulf; EUSTAR Co-authors. Annals of the rheumatic diseases. 2012.

[Of bugs and joints. Oligoarthritis caused by Tropheryma whipplei].

Koligi K; Mertz D; Benz D; Vogt T; Bloemberg GV; Winter L; Tyndall A; Battegay M; Walker UA. Der Internist. 2011.

Clinical images: Calcinosis and capillaries.

Aschwanden M; Jaeger K; Benz D; Tyndall A; Walker UA. Arthritis and rheumatism. 2011.

Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy.

Sevastianova K; Sutinen J; Greco D; Sievers M; Salmenkivi K; Perttilä J; Olkkonen VM; Wågsäter D; Lidell ME; Enerbäck S; Eriksson P; Walker UA; Auvinen P; Ristola M; Yki-Järvinen H. DIABETES. 2011.

Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion

Walker U.A.; Courvoisier D.S.; Dudler J.; Aeberli D.; von Kempis J.; Scherer A.; Finckh A.. Rheumatology (United Kingdom). 2011.

Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement.

Weinberg ME; Roman MC; Jacob P; Wen M; Cheung P; Walker UA; Mulligan K; Schambelan M. PLoS One. 2011.

EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research.

Beyer C; Distler JH; Allanore Y; Aringer M; Avouac J; Czirják L; Cutolo M; Damjanov N; Del Galdo F; Fligelstone K; Guiducci S; Kowal-Bielecka O; van Laar JM; Martucci-Cerinic M; Müller-Ladner U; Riemekasten G; Tarner IH; Tyndall A; Kennedy AT; Valentini G; Vettori S; Walker UA; Denton C; Distler O; EUSTAR Biobanking Group.. Annals of the rheumatic diseases. 2011.

Late-onset systemic sclerosis--a systematic survey of the EULAR scleroderma trials and research group database.

Hügle T; Schuetz P; Daikeler T; Tyndall A; Matucci-Cerinic M; Walker UA; van Laar JM; EUSTAR members.. Rheumatology (United Kingdom). 2011.

Nail fold capillaroscopy differs widely between systemic sclerosis and chronic graft vs host disease of the skin

Aschwanden, Markus; Halter, Joerg P.; Walker, Ulrich A.; Staub, Daniel; Tichelli, Andre; Daikeler, Thomas; Jaeger, Kurt A.; Tyndall, Alan. Rheumatology (United Kingdom). 2011.

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.

Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M; EUSTAR Group.. Annals of the rheumatic diseases. 2011.

Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey.

Côté HC; Gerschenson M; Walker UA; Miro O; Garrabou G; Hammond E; Villarroya J; Giralt M; Villarroya F; Cinque P; Garcia-Arumi E; Andreu AL; Pinti M; Cossarizza A. MITOCHONDRION. 2011.

Registries in systemic sclerosis: a worldwide experience.

Galluccio F; Walker UA; Nihtyanova S; Moinzadeh P; Hunzelmann N; Krieg T; Steen V; Baron M; Sampaio-Barros P; Kayser C; Nash P; Denton CP; Tyndall A; Müller-Ladner U; Matucci-Cerinic M. Rheumatology (United Kingdom). 2011.

Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans.

Pöllinger,Bernadette; Junt,Tobias; Metzler,Barbara; Walker,Ulrich A; Tyndall,Alan; Allard,Cyril; Bay,Serkan; Keller,Roland; Raulf,Friedrich; Di Padova,Franco; O'Reilly,Terrence; Horwood,Nicole J; Patel,Dhavalkumar D; Littlewood-Evans,Amanda. Journal of immunology (Baltimore, Md. : 1950). 2011.

A metabolic cause of spinal deformity.

Effelsberg NM; Hügle T; Walker UA. METABOLISM-CLINICAL AND EXPERIMENTAL. 2010.

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.

Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA. Annals of the rheumatic diseases. 2010.

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.

Avouac J; Walker U; Tyndall A; Kahan A; Matucci-Cerinic M; Allanore Y; EUSTAR.; Miniati I; Muller A; Iannone F; Distler O; Becvar R; Sierakowsky S; Kowal-Bielecka O; Coelho P; Cabane J; Cutolo M; Shoenfeld Y; Valentini G; Rovensky J; Riemekasten G; Vlachoyiannopoulos P; Caporali R; Jiri S; Inanc M; Zimmermann Gorska I; Carreira P; Novak S; Czirjak L; Oliveira Ramos F; Jendro M; Chizzolini C; Kucharz EJ; Richter J; Cozzi F; Rozman B; Mallia CM; Gabrielli A; Farge D; Kiener HP; Schöffel D; Airo P; Wollheim F; Martinovic D; Trotta F; Jablonska S; Reich K; Bombardieri S; Siakka P; Pellerito R; Bambara LM; Morovic-Vergles J; Denton C; Hinrichs R; Van den Hoogen F; Damjanov N; Kötter I; Ortiz V; Heitmann S; Krasowska D; Seidel M; Hasler P; Van Laar JM; Kaltwasser JP; Foeldvari I; Juan Mas A; Bajocchi G; Wislowska M; Pereira Da Silva JA; Jacobsen S; Worm M; Graniger W; Kuhn A; Stankovic A; Cossutta R; Majdan M; Damjanovska Rajcevska L; Tikly M; Nasonov EL; Steinbrink K; Herrick A; Müller-Ladner U; Dinc A; Scorza R; Sondergaard K; Indiveri F; Nielsen H; Szekanecz Z; Silver RM; Antivalle M; Espinosa IB; García de la Pena Lefebvre P; Midtvedt O; Launay D; Valesini F; Tuvik P; Ionescu RM; Del Papa N; Pinto S; Wigley F; Mihai C; Sinziana Capranu M; Sunderkötter C; Jun JB; Alhasani S; Distler JH; Ton E; Soukup T; Seibold J; Zeni S; Nash P; Mouthon L; De Keyser F; Duruöz MT; Cantatore FP; Strauss G; von Mülhen CA; Pozzi MR; Eyerich K; Szechinski J; Keiserman M; Houssiau FA; Román-Ivorra JA; Krummel-Lorenz B; Aringer M; Westhovens R; Bellisai F; Mayer M; Stoeckl F; Uprus M; Volpe A; Buslau M; Yavuz S; Granel B; Valderílio Feijó A; Del Galdo F; Popa S; Zenone T; Ricardo Machado X; Pileckyte M; Stebbings S; Mathieu A; Tulli A; Tourinho T; Souza R; Acayaba de Toledo R; Stamp L; Solanki K; Veale D; Francisco Marques Neto J; Bagnato GF; Loyo E; Toloza S; Li M; Ahmed Abdel Atty Mohamed W; Cobankara V; Olas J; Salsano F; Oksel F; Tanaseanu CM; Foti R; Ancuta C; Vonk M; Caramashi P; Beretta L; Balbir A; Chiàla A; Pasalic Simic K; Ghio M; Stamenkovic B; Rednic S; Host N; Pellerito R; Hachulla E; Furst DE. Journal of Rheumatology. 2010.

Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.

Rizzi M; Knoth R; Hampe CS; Lorenz P; Gougeon ML; Lemercier B; Venhoff N; Ferrera F; Salzer U; Thiesen HJ; Peter HH; Walker UA; Eibel H. PLoS One. 2010.

Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues.

Venhoff N; Lebrecht D; Deveaud C; Beauvoit B; Bonnet J; Müller K; Kirschner J; Venhoff AC; Walker UA. AIDS (London, England). 2010.

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis.

Allanore Y; Meune C; Vonk MC; Airo P; Hachulla E; Caramaschi P; Riemekasten G; Cozzi F; Beretta L; Derk CT; Komócsi A; Farge D; Balbir A; Riccieri V; Distler O; Chialà A; Del Papa N; Simic KP; Ghio M; Stamenkovic B; Rednic S; Host N; Pellerito R; Zegers E; Kahan A; Walker UA; Matucci-Cerinic M; EUSTAR co-authors.. Annals of the rheumatic diseases. 2010.

Respiratory chain deficiency precedes the disrupted calcium homeostasis in chronic doxorubicin cardiomyopathy.

Lebrecht D; Kirschner J; Geist A; Haberstroh J; Walker UA. CARDIOVASCULAR PATHOLOGY. 2010.

Role of pyrimidine depletion in the mitochondrial cardiotoxicity of nucleoside analogue reverse transcriptase inhibitors.

Balcarek K; Venhoff N; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Venhoff AC; Lebrecht D; Walker UA. Journal of Acquired Immune Deficiency Syndromes. 2010.

Skeletal muscle mitochondrial DNA content and aerobic metabolism in patients with antiretroviral therapy-associated lipoatrophy.

Sutinen J; Laaksonen MS; Walker UA; Setzer B; Kemppainen J; Nuutila P; Yki-Järvinen H. Journal of Antimicrobial Chemotherapy. 2010.

Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis.

Dudler J; Finckh A; Kyburz D; Langenegger T; Möller B; Schmiedel U; Walker UA. Swiss medical weekly. 2010.

Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229.

McComsey GA; Walker UA; Budhathoki CB; Su Z; Currier JS; Kosmiski L; Naini LG; Charles S; Medvik K; Aberg JA; AIDS Clinical Trials Group A5229 Team.. AIDS (London, England). 2010.

Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions.

Aschwanden M; Kesten F; Stern M; Thalhammer C; Walker UA; Tyndall A; Jaeger KA; Hess C; Daikeler T. Annals of the rheumatic diseases. 2010.

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

Finckh A; Ciurea A; Brulhart L; Möller B; Walker UA; Courvoisier D; Kyburz D; Dudler J; Gabay C; Arthritis.. Annals of the rheumatic diseases. 2010.

[Scleroderma and fibrosing diseases].

Walker UA; Knöss P; Jakobs M; Krenn V. ZEITSCHRIFT FUR RHEUMATOLOGIE. 2009.

Erectile dysfunction in systemic sclerosis.

Walker UA; Tyndall A; Ruszat R. Annals of the rheumatic diseases. 2009.

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells.

Distler JH; Allanore Y; Avouac J; Giacomelli R; Guiducci S; Moritz F; Akhmetshina A; Walker UA; Gabrielli A; Müller-Ladner U; Tyndall A; Matucci-Cerinic M; Distler O; EULAR Scleroderma Trials and Research group.. Annals of the rheumatic diseases. 2009.

Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.

Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J. Journal of Infectious Diseases. 2009.

Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database.

Walker UA; Tyndall A; Czirják L; Denton CP; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Matucci-Cerinic M; EUSTAR co-authors.. Annals of the rheumatic diseases. 2009.

HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV.

Kremer H; Sonnenberg-Schwan U; Arendt G; Brockmeyer NH; Potthoff A; Ulmer A; Graefe K; Lorenzen T; Starke W; Walker UA; German Competence Network HIV/AIDS.. EUROPEAN JOURNAL OF MEDICAL RESEARCH. 2009.

Mitochondrial DNA depletion in rat liver induced by fosalvudine tidoxil, a novel nucleoside reverse transcriptase inhibitor prodrug.

Venhoff AC; Lebrecht D; Reuss FU; Heckl-Ostreicher B; Wehr R; Walker UA; Venhoff N. Antimicrobial agents and chemotherapy. 2009.

Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.

Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA. Antiviral therapy. 2009.

Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats.

Lebrecht D; Venhoff AC; Kirschner J; Wiech T; Venhoff N; Walker UA. Journal of Acquired Immune Deficiency Syndromes. 2009.

Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study.

Venhoff N; Rizzi M; Salzer U; Bossaller L; Thoden J; Eibel H; Walker UA. Annals of the rheumatic diseases. 2009.

More about masitinib.

Walker UA. Arthritis Research and Therapy. 2009.

Multisegmental spondylitis due to Tropheryma whipplei: case report.

Spoerl D; Bär D; Cooper J; Vogt T; Tyndall A; Walker UA. Orphanet Journal of Rare Diseases. 2009.

Pathogenesis of bone disorders in HIV infection

Venhoff N.; Walker U.A.. International Journal of Clinical Rheumatology. 2009.

Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?

Hügle T; Gratzl S; Daikeler T; Frey D; Tyndall A; Walker UA. Annals of the rheumatic diseases. 2009.

Tenofovir-induced osteomalacia.

Wanner DP; Tyndall A; Walker UA. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2009.

[Safety and efficacy of biologics directed against TNF-alpha and CD20 in the therapy of vasculitis and systemic lupus erythematosus].

Walker UA; Hasler P. Therapeutische Umschau. Revue therapeutique. 2008.

Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study.

McComsey GA; Lo Re V 3rd; O'Riordan M; Walker UA; Lebrecht D; Baron E; Mounzer K; Frank I. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008.

Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.

Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA. AIDS (London, England). 2008.

Imaging tools for the clinical assessment of idiopathic inflammatory myositis.

Walker UA. CURRENT OPINION IN RHEUMATOLOGY. 2008.

Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.

McComsey GA; Kang M; Ross AC; Lebrecht D; Livingston E; Melvin A; Hitti J; Cohn SE; Walker UA; AIDS Clinical Trials Group A5084.. HIV clinical trials. 2008.

Lipoatrophy and Other Manifestations of Antiretroviral Therapeutics

Walker U.A.. . 2008.

Pharmacokinetics of zidovudine and lamivudine during oral uridine supplementation with NucleomaxX.

Venhoff N; Venhoff AC; Jayewardene AL; Aweeka F; Lebrecht D; Walker UA. Journal of Acquired Immune Deficiency Syndromes. 2008.

Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine.

Setzer B; Lebrecht D; Walker UA. AMERICAN JOURNAL OF PATHOLOGY. 2008.

Rheumatic conditions in human immunodeficiency virus infection.

Walker UA; Tyndall A; Daikeler T. Rheumatology (United Kingdom). 2008.

Safety and efficacy of biologics directed against TNF-α and CD20 in the therapy of vasculitis and systemic lupus erythematosus Stellenwert von gegen TNF-α und CD20 gerichteten biologika in der therapie der vaskulitis und des systemischen lupus erythematodes

Walker U.A.; Hasler P.. Therapeutische Umschau. Revue therapeutique. 2008.

Ultrasonography in the assessment of peripheral joint involvement in psoriatic arthritis : a comparison with radiography, MRI and scintigraphy.

Weiner SM; Jurenz S; Uhl M; Lange-Nolde A; Warnatz K; Peter HH; Walker UA. CLINICAL RHEUMATOLOGY. 2008.

Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.

Lebrecht D; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Walker UA. Arthritis and rheumatism. 2008.

Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices.

McComsey GA; O'Riordan M; Setzer B; Lebrecht D; Baron E; Walker UA. EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2008.

Antiretroviral therapy-induced liver alterations.

Walker UA. Current Opinion in HIV and AIDS. 2007.

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.

Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M. Annals of the rheumatic diseases. 2007.

Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.

Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Walker UA. BRITISH JOURNAL OF PHARMACOLOGY. 2007.

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005.

Tyndall A; Walker UA; Cope A; Dazzi F; De Bari C; Fibbe W; Guiducci S; Jones S; Jorgensen C; Le Blanc K; Luyten F; McGonagle D; Martin I; Bocelli-Tyndall C; Pennesi G; Pistoia V; Pitzalis C; Uccelli A; Wulffraat N; Feldmann M. Arthritis Research and Therapy. 2007.

Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.

Venhoff N; Setzer B; Melkaoui K; Walker UA. Antiviral therapy. 2007.

Role of mtDNA lesions in anthracycline cardiotoxicity.

Lebrecht D; Walker UA. Cardiovascular Toxicology. 2007.

Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.

Sutinen J; Walker UA; Sevastianova K; Klinker H; Häkkinen AM; Ristola M; Yki-Järvinen H. Antiviral therapy. 2007.